Optometry360 Logo White
  • Conferences
  • Videos
  • Podcasts
  • Quizzes
  • About
    • About Us – Mission
    • Content Awards
    • Media Partners
    • Business Team
    • Brand Ambassadors
    • Industry Council
    • Advisory Board

What are you looking for?

  • Anterior Segment
  • Cataract
  • Cornea and External Disease
  • Diabetic Macular Edema
  • Dry Eye
  • Early Onset Cataracts
  • Exclusives
  • General
  • Geographic Atrophy
  • Glaucoma
  • Industry News
  • Inherited Retinal Disease
  • IOLs
  • Neurotrophic Keratitis
  • Ocular Surface Disease
  • Oculoplastics
  • Optometry
  • Pediatrics
  • Practice Management
  • Presbyopia
  • Refractive Surgery/Vision Correction
  • Residents & Young Ophthalmologists
  • Retina
  • Retina Care 360
  • Retinopathy of Prematurity
  • Spotlight Series
  • The Interventional Glaucoma Project
  • The Ophthalmic Project
  • Trending Topics
Spotlight - The Future of Cryopreserved Amniotic Membrane in Oculoplastic Surgery
Optometry360 Logo White
  • Conferences
  • Videos
  • Podcasts
  • Quizzes
  • About
    • About Us – Mission
    • Content Awards
    • Media Partners
    • Business Team
    • Brand Ambassadors
    • Industry Council
    • Advisory Board
Home > Industry News > Ophthalmic research technology platform launches
  • Industry News

Ophthalmic research technology platform launches

Ophthalmology 360

The Ora EyeCup (Ora, Inc), a smartphone attachment and software application that allows patients to take high-resolution images of their eyes and track disease signs and symptoms remotely, has launched.

The Ora EyeCup is a finalist in the Most Valuable Clinical Technology Award category at the Reuters Events Pharma Awards USA 2022

“At Ora, our technologists have spent the past 2 years developing this revolutionary system to capture patient data and provide a deeper understanding of therapeutic effect,” notes Dr. De Moraes. “The result is a trailblazing technology that captures high quality therapeutic data and improves the likelihood of study success.”

Read the full press release here.

Share

Related Content

  • Retina

Heidelberg receives FDA clearance for updated SPECTRALIS software

FDA approves Beovu label update to include safety information
  • Cataract

FDA approves first and only extended depth of focus IOL for cataract patients

  • Retina Care 360

Phase 3 SOL-1 trial results are a “landmark achievement” for investigational TKI therapy for wet AMD

  • Industry News

Topcon Healthcare partners with RemoniHealth on remote eye care

1 Min Read
  • Cornea and External Disease

DefEYE Inc launches as independent ophthalmic biologics company

  • Industry News

Harrow to acquire Melt Pharmaceuticals to expand non-opioid sedation options

Share

Editor's Picks

  • Neurotrophic Keratitis

Topical insulin shows real-world benefit in neurotrophic keratopathy

  • Retina

GLP-1 RAs have protective effects against AMD

  • Retina

Four-month injection intervals appear safe for long-term stable nAMD

Advisory Board

Saad Ahmad, MD

Ahmad A. Aref, MD, MBA

Roomasa Channa, MD

David Chow, MD, FRCS(C)

Sally L. Baxter, MD, MSc

Neel R. Desai, MD

Nadia Haqqie, MD

Simon Fung, MD, FRCOphth

Sumit Garg, MD

Ross Lakhanpal, MD, FACS

Sanjai Jalaj, MD

Anton Kolomeyer, MD, PhD

Shan Lin, MD

Steven R. Sarkisian, Jr., MD

See All
Optometry360 Logo

Ophthalmology 360® is a dynamic digital platform dedicated to advancing the field of eye care.

Get to Know Us

  • Home
  • About Us
  • Media Partners
  • Advertising Policy
  • Our Advisory Board

Sign up for our Newsletter

Sign up for our Newsletter to get our newest articles instantly!

  • Privacy Policy
  • Advertising Policy
  • Medical Disclaimer
IHM Logo

2026 Ophthalmology 360 is a trademark of International Healthcare Media, LLC. All rights reserved

  • MedJournal360 Icon
  • RareDisease360 Icon
  • MyHero360 Icon
  • Optometry360 Icon
  • Ophtalmology360 Icon